Herwig Gerlach

60.0k total citations · 7 hit papers
139 papers, 14.2k citations indexed

About

Herwig Gerlach is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Herwig Gerlach has authored 139 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Epidemiology, 52 papers in Pulmonary and Respiratory Medicine and 38 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Herwig Gerlach's work include Sepsis Diagnosis and Treatment (51 papers), Respiratory Support and Mechanisms (42 papers) and Renal function and acid-base balance (17 papers). Herwig Gerlach is often cited by papers focused on Sepsis Diagnosis and Treatment (51 papers), Respiratory Support and Mechanisms (42 papers) and Renal function and acid-base balance (17 papers). Herwig Gerlach collaborates with scholars based in Germany, United States and France. Herwig Gerlach's co-authors include Jean‐Louis Vincent, Jean Carlet, Didier Keh, Graham Ramsay, Mitchell M. Levy, John C. Marshall, Margaret M. Parker, R. Phillip Dellinger, Konrad Reinhart and Henry Masur and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Herwig Gerlach

138 papers receiving 13.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

2004 2.3k citations R. Phillip Dellinger, Jean Carlet et al. Intensive Care Medicine profile →
Sepsis in European intensive care units: Results of the SOAP study*

2006 2.0k citations Jean‐Louis Vincent, Yasser Sakr et al. Critical Care Medicine profile →
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

2004 2.0k citations R. Phillip Dellinger, Jean Carlet et al. Critical Care Medicine profile →
Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.

1990 689 citations Matthias Clauss, Marlene L. Gerlach et al. The Journal of Experimental Medicine profile →
The Surviving Sepsis Campaign: Results of an international guideline-based performance improvement program targeting severe sepsis*

2010 679 citations Mitchell M. Levy, R. Phillip Dellinger et al. Critical Care Medicine profile →
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis

2010 583 citations Mitchell M. Levy, R. Phillip Dellinger et al. Intensive Care Medicine profile →
Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019— results from a systematic review and meta-analysis

2020 455 citations Michael Bauer, Herwig Gerlach et al. Critical Care profile →

Peers

Countries citing papers authored by Herwig Gerlach

Since Specialization

Citations

This map shows the geographic impact of Herwig Gerlach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herwig Gerlach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herwig Gerlach more than expected).

Fields of papers citing papers by Herwig Gerlach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herwig Gerlach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herwig Gerlach. The network helps show where Herwig Gerlach may publish in the future.

Co-authorship network of co-authors of Herwig Gerlach

This figure shows the co-authorship network connecting the top 25 collaborators of Herwig Gerlach. A scholar is included among the top collaborators of Herwig Gerlach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herwig Gerlach. Herwig Gerlach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sterblichkeit bei Sepsis und septischem Schock in Deutschland. Ergebnisse eines systematischen Reviews mit Metaanalyse 2021 ·Der Anaesthesist ·Michael Bauer, Heinrich V. Groesdonk, Franziska Preissing, Petra Dickmann, Tobias Vogelmann, Herwig Gerlach	13
2	Year in review in Intensive Care Medicine 2010: I. Acute renal failure, outcome, risk assessment and ICU performance, sepsis, neuro intensive care and experimentals 2011 ·Intensive Care Medicine ·Massimo Antonelli, Élie Azoulay, Marc J. M. Bonten, Jean Chastre, Giuseppe Citerio, Giorgio Conti, Daniel De Backer, Herwig Gerlach, Göran Hedenstierna, Michael Joannidis, Duncan Macrae, Jordi Mancebo, Salvatore Maurizio Maggiore, Alexandre Mebazaa, Jean‐Charles Preiser, Jérôme Pugin, Jan Wernerman, Haibo Zhang	5
3	The Surviving Sepsis Campaign: Results of an international guideline-based performance improvement program targeting severe sepsis* breakdown → 2010 ·Critical Care Medicine ·Mitchell M. Levy, R. Phillip Dellinger, Sean R. Townsend, Walter T. Linde‐Zwirble, John C. Marshall, Julian Bion, Christa Schorr, Antonio Artigas, Graham Ramsay, Richard Beale, Margaret M. Parker, Herwig Gerlach, Konrad Reinhart, Eliézer Silva, Maurene A. Harvey, Susan Regan, Derek C. Angus	679
4	Year in review in Intensive Care Medicine, 2008: III. Paediatrics, Ethics, outcome research and critical care organization, sedation, pharmacology and miscellanea 2009 ·Intensive Care Medicine ·Massimo Antonelli, Élie Azoulay, Marc J. M. Bonten, Jean Chastre, Giuseppe Citerio, Giorgio Conti, Daniel De Backer, François Lemaire, Herwig Gerlach, Johan Groeneveld, Göran Hedenstierna, Duncan Macrae, Jordi Mancebo, Salvatore Maurizio Maggiore, Alexandre Mebazaa, Philipp Metnitz, Jérôme Pugin, Jan Wernerman, Haibo Zhang	4
5	Practice and perception—A nationwide survey of therapy habits in sepsis* 2008 ·Critical Care Medicine ·Frank M. Brunkhorst, Christoph Engel, Max Ragaller, Tobias Welte, Rolf Rossaint, Herwig Gerlach, Konstantin Mayer, Stefan John, Frank Stüber, Norbert Weiler, Michael Oppert, Onnen Moerer, Holger Bogatsch, Konrad Reinhart, Markus Loeffler, Christiane S. Hartog	87
6	Diagnose und Therapie der Sepsis S-2-Leitlinien der Deutschen Sepsis-Gesellschaft e.V. (DSG) und der Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin (DIVI) 2006 ·Der Anaesthesist ·Konrad Reinhart, Frank M. Brunkhorst, Hans-Georg Bone, Herwig Gerlach, Matthias Gründling, G. Kreymann, P. Kujath, G. Marggraf, Kerstin Mayer, Andreas Meier‐Hellmann, C. Peckelsen, Christian Putensen, Michael Quintel, (unknown), Rolf Rossaint, Frank Stüber, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	8
7	Sepsis in European intensive care units: Results of the SOAP study* breakdown → 2006 ·Critical Care Medicine ·Jean‐Louis Vincent, Yasser Sakr, Charles L. Sprung, V. Marco Ranieri, Konrad Reinhart, Herwig Gerlach, Rui P. Moreno, Jean Carlet, Jean‐Roger Le Gall, Didier Payen	2020
8	Is albumin administration in the acutely ill associated with increased mortality? Results of the SOAP study 2005 ·Critical Care ·Jean‐Louis Vincent, Yasser Sakr, Konrad Reinhart, Charles L. Sprung, Herwig Gerlach, V. Marco Ranieri, (unknown)	63
9	Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock breakdown → 2004 ·Critical Care Medicine ·R. Phillip Dellinger, Jean Carlet, Henry Masur, Herwig Gerlach, Thierry Calandra, Jonathan Cohen, Juan Gea‐Banacloche, Didier Keh, John C. Marshall, Margaret M. Parker, Graham Ramsay, Janice L. Zimmerman, Jean‐Louis Vincent, Mitchell M. Levy	1972
10	Reply to Zandstra and van der Voort 2004 ·Intensive Care Medicine ·R. Phillip Dellinger, Herwig Gerlach, Jean Carlet	175
11	Dose–Response Characteristics during Long-Term Inhalation of Nitric Oxide in Patients with Severe Acute Respiratory Distress Syndrome: A Prospective, Randomized, Controlled Study 2003 ·American Journal of Respiratory and Critical Care Medicine ·Herwig Gerlach, Didier Keh, (unknown), Thilo Busch, Klaus Lewandowski, D. Pappert, Rolf Rossaint, K. J. Falke	119
12	Immunologic and Hemodynamic Effects of “Low-Dose” Hydrocortisone in Septic Shock: A Double-Blind, Randomized, Placebo-controlled, Crossover Study 2003 ·American Journal of Respiratory and Critical Care Medicine ·Didier Keh, (unknown), Steffen Weber‐Carstens, (unknown), Olaf Ahlers, Sven Bercker, Hans‐Dieter Volk, Wolf‐Dietrich Doecke, K. J. Falke, Herwig Gerlach	415
13	Nitric oxide inhibits tissue factor synthesis, expression and activity in human monocytes by prior formation of peroxynitrite 1998 ·Intensive Care Medicine ·Max Gerlach, Didier Keh, G. Bezold, (unknown), (unknown), R.U. Peter, K. J. Falke, Herwig Gerlach	25
14	Morphological changes in chest radiographs of patients with acute respiratory distress syndrome (ARDS) 1998 ·Intensive Care Medicine ·J. Mäurer, (unknown), Herwig Gerlach, D. Pappert, Johannes Hierholzer, K. J. Falke, R. Félix	5
15	Evidence of nitric oxide in the exhaled gas of Asian elephants (Elephas maximus) 1996 ·Respiration Physiology ·Klaus Lewandowski, Thilo Busch, (unknown), U. Keske, Herwig Gerlach, K. J. Falke	16
16	Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome 1993 ·Intensive Care Medicine ·Herwig Gerlach, D. Pappert, K. Lewandowski, Rolf Rossaint, K. J. Falke	182
17	Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. breakdown → 1990 ·The Journal of Experimental Medicine ·Matthias Clauss, Marlene L. Gerlach, Herwig Gerlach, J Brett, F. Wang, P C Familletti, Y C Pan, Jitka V. Olander, Daniel T. Connolly, D Stern	689
18	Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. 1989 ·The Journal of Experimental Medicine ·Ciro Esposito, Herwig Gerlach, J Brett, D Stern, Helen Vlassara	303
19	Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. 1989 ·The Journal of Experimental Medicine ·J Brett, Herwig Gerlach, Peter P. Nawroth, Susan Steinberg, Gabriel C. Godman, D Stern	331
20	Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas. 1988 ·The Journal of Experimental Medicine ·Peter P. Nawroth, Dean A. Handley, Gary R. Matsueda, Rob de Waal, Herwig Gerlach, Dietmar Blohm, D Stern	136

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact